Effective drugs used to combat SARS-CoV-2 infection and the current status of vaccines

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a causal factor of the coronavirus disease 2019 (COVID-19). Drug repurposing, portraying patented drugs as a successful drug development technique, could shorten the period and minimize costs relative to de novo drug exploration. Recent...

Descripción completa

Detalles Bibliográficos
Autores principales: Awadasseid, Annoor, Wu, Yanling, Tanaka, Yoshimasa, Zhang, Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Masson SAS. 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843108/
https://www.ncbi.nlm.nih.gov/pubmed/33550043
http://dx.doi.org/10.1016/j.biopha.2021.111330

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843108/
https://www.ncbi.nlm.nih.gov/pubmed/33550043
http://dx.doi.org/10.1016/j.biopha.2021.111330

Ejemplares similares